OR WAIT null SECS
August 24, 2023
In this Q&A, Matt Smith, Vice President Research Site Development, Slope discusses the competition pharma companies and trial sponsors face when trying to become a sponsor of choice and build trust with sites and patients.
December 10, 2020
The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.
August 13, 2020
Recent case study highlights the importance of applying statistical rigor throughout the development and validation processes of biomarkers.
Distinguishing CAR-T and CPI approaches and the clinical trial challenges and complexities associated with each.
A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.
June 02, 2017
May 15, 2017
Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.
February 07, 2017
The war on cancer has seen significant strides made in the search for a cure, however, recent data suggests that the work is far from over.
April 01, 2016
How to meet the rigorous safety and efficacy demands critical to evaluating newer targeted cancer therapies.
March 23, 2016